Syngene International balance sheet

As of Sep 2026

Total assets: ₹6,659cr+1.8% on Sep 2025
Shareholders' equity: ₹4,859cr+2.6% on Sep 2025
Total debt: ₹67.2cr−46.0% on Sep 2025
Cash and investments: ₹529cr−36.9% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	2,448	2,545	2,323	2,378	2,383
	1,141	1,040	1,261	837	177
	21.0	31.5	34.3	41.1	48.1
	407	423	445	431	235
	4.7	5.3	4.7	1.3	—
	201	285	36.2	34.7	94.1
	219	342	216	223	235
	420	627	252	258	329
	93.0	101	29.5	40.7	69.6
	177	139	159	206	163
	4,710	4,912	4,509	4,193	3,406
	168	141	156	239	333
	409	456	611	513	824
	386	509	527	442	529
	120	229	367	85.7	89.5
	0.8	604	420	478	442
	679	37.3	77.6	90.0	101
	1,595	1,835	2,002	1,608	1,987
	186	166	130	112	106
	1,948	2,143	2,287	1,959	2,425
	6,659	7,055	6,796	6,152	5,831
Equity
	404	403	403	402	401
	4,455	4,436	4,324	3,856	3,217
	4,859	4,839	4,727	4,258	3,618
	4,859	4,839	4,727	4,258	3,618
Liabilities
	0.0	0.0	0.0	100	489
	439	447	411	365	236
	439	447	411	465	725
	0.0	18.0	43.3	40.7	43.7
	178	198	219	244	256
	617	663	673	750	1,025
	67.2	9.4	120	41.7	86.3
	303	348	352	256	258
	253	275	126	116	122
	624	632	597	413	466
	83.2	114	71.3	72.7	51.0
	8.4	27.7	8.4	47.6	14.7
	467	778	720	611	657
	1,183	1,552	1,396	1,144	1,188
	1,800	2,216	2,069	1,894	2,213
	6,659	7,055	6,796	6,152	5,831
Trade payables — MSME split
	60.4	58.8	34.1	—	—
	243	289	318	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SYNGENE₹398.60

Syngene International Ltd.

· Pharma & Health

₹ CrorePeersSAILIFE DIVISLAB WOCKPHARMA GLAND ASTERDM PPLPHARMA COHANCE LALPATHLABMcap ₹16,060 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	2,383.4	2,378.3	2,322.6	2,545.4	2,447.5
+ Capital Work-in-Progress	176.9	836.8	1,261.4	1,040.4	1,140.6
+ Investment Property	48.1	41.1	34.3	31.5	21.0
+ Other Intangibles	235.4	430.6	444.8	423.1	407.0
+ Intangibles under Development	—	1.3	4.7	5.3	4.7
+ Non-current Investments	94.1	34.7	36.2	285.0	200.5
+ Other Non-current Financial Assets	235.2	223.1	215.9	341.7	219.4
Non-current Financial Assets	329.3	257.8	252.1	626.7	419.9
+ Deferred Tax Assets	69.6	40.7	29.5	100.7	93.0
+ Other Non-current Assets	163.0	206.0	159.2	138.8	176.7
Total Non-current Assets	3,405.7	4,192.6	4,508.6	4,911.9	4,710.4
Current Assets
+ Inventories	332.8	238.5	155.5	141.3	167.8
+ Current Investments	824.4	513.2	610.5	456.1	409.3
+ Trade Receivables	529.3	441.6	526.7	508.8	385.5
+ Cash & Cash Equivalents	89.5	85.7	367.1	228.6	119.9
+ Other Bank Balances	442.2	477.8	419.9	604.4	0.8
+ Other Current Financial Assets	101.2	90.0	77.6	37.3	679.1
Current Financial Assets	1,986.6	1,608.3	2,001.8	1,835.2	1,594.6
+ Other Current Assets	105.9	112.2	130.0	166.3	185.7
Total Current Assets	2,425.3	1,959.0	2,287.3	2,142.8	1,948.1
Total Assets	5,831.0	6,151.6	6,795.9	7,054.7	6,658.5
Equity
+ Equity Share Capital	401.4	402.0	402.5	402.9	403.7
+ Other Equity / Reserves	3,216.6	3,855.7	4,324.3	4,436.2	4,455.1
Equity — Owners of Parent	3,618.0	4,257.7	4,726.8	4,839.1	4,858.8
Total Equity	3,618.0	4,257.7	4,726.8	4,839.1	4,858.8
Liabilities
+ Borrowings — Non-current	489.0	100.0	0.0	0.0	0.0
+ Other Non-current Financial Liab	235.7	365.1	410.6	447.4	439.1
Non-current Financial Liabilities	724.7	465.1	410.6	447.4	439.1
+ Provisions — Non-current	43.7	40.7	43.3	18.0	0.0
+ Other Non-current Liabilities	256.4	243.8	218.8	197.9	177.7
Non-current Liabilities	1,024.8	749.6	672.7	663.3	616.8
+ Borrowings — Current	86.3	41.7	119.6	9.4	67.2
+ Trade Payables	258.0	255.5	352.0	347.5	303.3
+ Other Current Financial Liab	121.6	115.9	125.5	275.0	253.4
Current Financial Liabilities	465.9	413.1	597.1	631.9	623.9
+ Provisions — Current	51.0	72.7	71.3	114.4	83.2
+ Current Tax Liabilities	14.7	47.6	8.4	27.7	8.4
+ Other Current Liabilities	656.6	610.9	719.6	778.3	467.4
Current Liabilities	1,188.2	1,144.3	1,396.4	1,552.3	1,182.9
Total Liabilities	2,213.0	1,893.9	2,069.1	2,215.6	1,799.7
Total Equity & Liabilities	5,831.0	6,151.6	6,795.9	7,054.7	6,658.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	34.1	58.8	60.4
+ Dues to Other Creditors — Current	—	—	317.9	288.7	242.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.